Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain-Reference-Cited by-同舟云学术

Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain

Published:2011-04-19 Issue:1 Volume:338 Page:114-124
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Ahn Kay,Smith Sarah E.,Liimatta Marya B.,Beidler David,Sadagopan Nalini,Dudley David T.,Young Tim,Wren Paul,Zhang Yanhua,Swaney Steven,Van Becelaere Keri,Blankman Jacqueline L.,Nomura Daniel K.,Bhattachar Shobha N.,Stiff Cory,Nomanbhoy Tyzoon K.,Weerapana Eranthie,Johnson Douglas S.,Cravatt Benjamin F.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity

2. Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

3. Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System

4. Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes

5. Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as Analgesics

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A brief review of anandamide in cannabis use and cannabis use disorder;Anandamide in Health and Disease;2025

2. Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use;Neuropsychopharmacology;2024-05-21

3. Finding new analgesics: Computational pharmacology faces drug discovery challenges;Biochemical Pharmacology;2024-04

4. Chemical proteomics to study metabolism, a reductionist approach applied at the systems level;Cell Chemical Biology;2024-03

5. Dysregulated expanded endocannabinoid system as therapeutic targets of amyotrophic lateral sclerosis;2024-01-15